The Rockefeller Foundation has announced the launch of a $30 million Advance Market Commitment aimed at scaling COVID-19 testing and safely reopening schools, communities, and the economy.

Made through RF Catalytic Capital, the foundation's public charity subsidiary, the investment will provide a financial guarantee and incentive for Thermo Fisher Scientific to procure and strategically stock up to $30 million of COVID-19 tests at a time. The tests will be distributed to the twenty-three states participating in Rockefeller's State and Territory Alliance for Testing (STAT), followed by other public and private buyers. The commitment is designed to ensure a ready supply of tests — in some cases at a lower price than states would pay if they were purchasing tests individually — while sending a clear signal to manufacturers to continue to ramp up production.